ACT_831/2025

System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Procedural & sub-applicationsCosts AssessmentsParis CDApplication For Costs—

Parties

Claimants

Roche Diabetes Care GmbH(Roche Group)

Reps: Christof Augenstein (Kather Augenstein Rechtsanwälte PartGmbB); Katharina Brandt (Kather Augenstein Rechtsanwälte PartGmbB); Robert Knaps (Kather Augenstein Rechtsanwälte PartGmbB); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbB)

Respondents

Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.

Reps: Charlotte Garnitsch (Taylor Wessing N.V.); Wim Maas (Taylor Wessing N.V.); Alexander Rubusch (Taylor Wessing Partnerschaftsgesellschaft mbB)

Judges

French-seated division — individual judges anonymized.

Panel member (anonymized)Presiding judge and judge-rapporteur
Panel member (anonymized)Legally qualified judge
Panel member (anonymized)Technically qualified judge

Patents

EP2196231

CPC codes: A61M2209/045, A61M5/148, A61M5/14244

Sector: Pharmaceutical & Medical

Outcome

Costs only

Filed: —

First decided: Apr 29, 2025

Language: —

The Central Division Paris issued a costs order in connection with the revocation action UPC_CFI_454/2023, requiring Tandem Diabetes to pay Roche Diabetes Care's representation and litigation costs. The Court rejected Tandem Diabetes's request to stay the costs proceedings pending the appeal against the decision on the merits.